{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T06:36:28Z","timestamp":1789540588698,"version":"build-2803163510"},"publisher-location":"New York, NY","reference-count":145,"publisher":"Springer New York","isbn-type":[{"value":"9781493933853","type":"print"},{"value":"9781493933877","type":"electronic"}],"license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016]]},"DOI":"10.1007\/978-1-4939-3387-7_17","type":"book-chapter","created":{"date-parts":[[2016,4,14]],"date-time":"2016-04-14T11:08:16Z","timestamp":1460632096000},"page":"313-351","source":"Crossref","is-referenced-by-count":17,"title":["Reverse Genetics Approaches to Control Arenavirus"],"prefix":"10.1007","author":[{"given":"Luis","family":"Mart\u00ednez-Sobrido","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benson Yee Hin","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Carlos","family":"de la Torre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,4,14]]},"reference":[{"key":"17_CR1","unstructured":"Buchmeier MJ, de la Torre, J. C., Peters, C. J. (2007) Arenaviridae: The Viruses and Their Replication. In: David Knipe P, Peter Howley, MD, Diane Griffin, MD, PhD, Robert Lamb, PhD, ScD, Malcolm Martin, MD, Bernard Roizman, ScD, Stephen Straus, MD, editor. Fields Virology. 5th ed. Philadelphia, PA, 19106, USA: Lippincott Williams & Wilkins. pp. 1791\u20131827"},{"key":"17_CR2","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1007\/s00705-015-2418-y","volume":"160","author":"SR Radoshitzky","year":"2015","unstructured":"Radoshitzky SR, Bao Y, Buchmeier MJ, Charrel RN, Clawson AN et al (2015) Past, present, and future of arenavirus taxonomy. Arch Virol 160:1851\u20131874","journal-title":"Arch Virol"},{"key":"17_CR3","doi-asserted-by":"publisher","first-page":"e1004900","DOI":"10.1371\/journal.ppat.1004900","volume":"11","author":"MD Stenglein","year":"2015","unstructured":"Stenglein MD, Jacobson ER, Chang LW, Sanders C, Hawkins MG et al (2015) Widespread recombination, reassortment, and transmission of unbalanced compound viral genotypes in natural arenavirus infections. PLoS Pathog 11:e1004900","journal-title":"PLoS Pathog"},{"key":"17_CR4","doi-asserted-by":"publisher","first-page":"e00779","DOI":"10.1128\/genomeA.00779-14","volume":"2","author":"MD Stenglein","year":"2014","unstructured":"Stenglein MD, Leavitt EB, Abramovitch MA, McGuire JA, DeRisi JL (2014) Genome sequence of a Bornavirus recovered from an African Garter snake (Elapsoidea loveridgei). Genome Announc 2:e00779\u2013e00814","journal-title":"Genome Announc"},{"key":"17_CR5","doi-asserted-by":"publisher","first-page":"e00180-00112","DOI":"10.1128\/mBio.00180-12","volume":"3","author":"MD Stenglein","year":"2012","unstructured":"Stenglein MD, Sanders C, Kistler AL, Ruby JG, Franco JY et al (2012) Identification, characterization, and in vitro culture of highly divergent arenaviruses from boa constrictors and annulated tree boas: candidate etiological agents for snake inclusion body disease. MBio 3:e00180-00112","journal-title":"MBio"},{"key":"17_CR6","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.antiviral.2007.10.010","volume":"78","author":"DA Enria","year":"2008","unstructured":"Enria DA, Briggiler AM, Sanchez Z (2008) Treatment of Argentine hemorrhagic fever. Antiviral Res 78:132\u2013139","journal-title":"Antiviral Res"},{"key":"17_CR7","doi-asserted-by":"publisher","first-page":"S110","DOI":"10.1038\/nm1142","volume":"10","author":"TW Geisbert","year":"2004","unstructured":"Geisbert TW, Jahrling PB (2004) Exotic emerging viral diseases: progress and challenges. Nat Med 10:S110\u2013S121","journal-title":"Nat Med"},{"key":"17_CR8","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.antiviral.2007.11.003","volume":"78","author":"SH Khan","year":"2008","unstructured":"Khan SH, Goba A, Chu M, Roth C, Healing T et al (2008) New opportunities for field research on the pathogenesis and treatment of Lassa fever. Antiviral Res 78:103\u2013115","journal-title":"Antiviral Res"},{"key":"17_CR9","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/978-3-642-56029-3_4","volume-title":"Arenaviruses I","author":"JB McCormick","year":"2002","unstructured":"McCormick JB, Fisher-Hoch SP (2002) Lassa Fever. In: Oldstone MB (ed) Arenaviruses I. Springer, Berlin, Heidelberg, New York, pp 75\u2013110"},{"key":"17_CR10","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/978-3-642-56029-3_3","volume-title":"Arenaviruses I","author":"CJ Peters","year":"2002","unstructured":"Peters CJ (2002) Human Infection with Arenaviruses in the Americas. In: Oldstone MB (ed) Arenaviruses I. Springer, Berlin, Heidelberg, New York, pp 65\u201374"},{"key":"17_CR11","first-page":"865","volume":"83","author":"DO Freedman","year":"1999","unstructured":"Freedman DO, Woodall J (1999) Emerging infectious diseases and risk to the traveler. Med Clin North Am 83:865\u2013883, v","journal-title":"Med Clin North Am"},{"key":"17_CR12","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1056\/NEJM199010183231607","volume":"323","author":"GP Holmes","year":"1990","unstructured":"Holmes GP, McCormick JB, Trock SC, Chase RA, Lewis SM et al (1990) Lassa fever in the United States. Investigation of a case and new guidelines for management. N Engl J Med 323:1120\u20131123","journal-title":"N Engl J Med"},{"key":"17_CR13","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1086\/322620","volume":"33","author":"M Isaacson","year":"2001","unstructured":"Isaacson M (2001) Viral hemorrhagic fever hazards for travelers in Africa. Clin Infect Dis 33:1707\u20131712","journal-title":"Clin Infect Dis"},{"key":"17_CR14","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1136\/bmj.327.7426.1271","volume":"327","author":"JK Richmond","year":"2003","unstructured":"Richmond JK, Baglole DJ (2003) Lassa fever: epidemiology, clinical features, and social consequences. BMJ 327:1271\u20131275","journal-title":"BMJ"},{"key":"17_CR15","doi-asserted-by":"publisher","first-page":"e1000455","DOI":"10.1371\/journal.ppat.1000455","volume":"5","author":"T Briese","year":"2009","unstructured":"Briese T, Paweska JT, McMullan LK, Hutchison SK, Street C et al (2009) Genetic detection and characterization of Lujo virus, a new hemorrhagic fever-associated arenavirus from southern Africa. PLoS Pathog 5:e1000455","journal-title":"PLoS Pathog"},{"key":"17_CR16","doi-asserted-by":"crossref","first-page":"813","DOI":"10.4269\/ajtmh.1965.14.813","volume":"14","author":"ML Kuns","year":"1965","unstructured":"Kuns ML (1965) Epidemiology of Machupo virus infection. II. Ecological and control studies of hemorrhagic fever. Am J Trop Med Hyg 14:813\u2013816","journal-title":"Am J Trop Med Hyg"},{"key":"17_CR17","doi-asserted-by":"crossref","first-page":"531","DOI":"10.4269\/ajtmh.1967.16.531","volume":"16","author":"PA Webb","year":"1967","unstructured":"Webb PA, Johnson KM, Mackenzie RB, Kuns ML (1967) Some characteristics of Machupo virus, causative agent of Bolivian hemorrhagic fever. Am J Trop Med Hyg 16:531\u2013538","journal-title":"Am J Trop Med Hyg"},{"key":"17_CR18","doi-asserted-by":"publisher","first-page":"e1000047","DOI":"10.1371\/journal.ppat.1000047","volume":"4","author":"S Delgado","year":"2008","unstructured":"Delgado S, Erickson BR, Agudo R, Blair PJ, Vallejo E et al (2008) Chapare virus, a newly discovered arenavirus isolated from a fatal hemorrhagic fever case in Bolivia. PLoS Pathog 4:e1000047","journal-title":"PLoS Pathog"},{"key":"17_CR19","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1006\/viro.1996.0381","volume":"221","author":"JP Gonzalez","year":"1996","unstructured":"Gonzalez JP, Bowen MD, Nichol ST, Rico-Hesse R (1996) Genetic characterization and phylogeny of Sabia virus, an emergent pathogen in Brazil. Virology 221:318\u2013324","journal-title":"Virology"},{"key":"17_CR20","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1086\/501607","volume":"20","author":"LR Armstrong","year":"1999","unstructured":"Armstrong LR, Dembry LM, Rainey PM, Russi MB, Khan AS et al (1999) Management of a Sabia virus-infected patients in a US hospital. Infect Control Hosp Epidemiol 20:176\u2013182","journal-title":"Infect Control Hosp Epidemiol"},{"key":"17_CR21","doi-asserted-by":"crossref","first-page":"452","DOI":"10.4269\/ajtmh.1994.50.452","volume":"50","author":"RB Tesh","year":"1994","unstructured":"Tesh RB, Jahrling PB, Salas R, Shope RE (1994) Description of Guanarito virus (Arenaviridae: Arenavirus), the etiologic agent of Venezuelan hemorrhagic fever. Am J Trop Med Hyg 50:452\u2013459","journal-title":"Am J Trop Med Hyg"},{"key":"17_CR22","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1006\/viro.1999.0067","volume":"266","author":"SC Weaver","year":"2000","unstructured":"Weaver SC, Salas RA, de Manzione N, Fulhorst CF, Duno G et al (2000) Guanarito virus (Arenaviridae) isolates from endemic and outlying localities in Venezuela: sequence comparisons among and within strains isolated from Venezuelan hemorrhagic fever patients and rodents. Virology 266:189\u2013195","journal-title":"Virology"},{"key":"17_CR23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4269\/ajtmh.1995.53.1","volume":"53","author":"JP Gonzalez","year":"1995","unstructured":"Gonzalez JP, Sanchez A, Rico-Hesse R (1995) Molecular phylogeny of Guanarito virus, an emerging arenavirus affecting humans. Am J Trop Med Hyg 53:1\u20136","journal-title":"Am J Trop Med Hyg"},{"key":"17_CR24","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1006\/viro.1996.0512","volume":"224","author":"CF Fulhorst","year":"1996","unstructured":"Fulhorst CF, Bowen MD, Ksiazek TG, Rollin PE, Nichol ST et al (1996) Isolation and characterization of Whitewater Arroyo virus, a novel North American arenavirus. Virology 224:114\u2013120","journal-title":"Virology"},{"key":"17_CR25","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1006\/viro.2001.0874","volume":"283","author":"RN Charrel","year":"2001","unstructured":"Charrel RN, de Lamballerie X, Fulhorst CF (2001) The Whitewater Arroyo virus: natural evidence for genetic recombination among Tacaribe serocomplex viruses (family Arenaviridae). Virology 283:161\u2013166","journal-title":"Virology"},{"key":"17_CR26","doi-asserted-by":"publisher","first-page":"401","DOI":"10.3201\/eid1803.111602","volume":"18","author":"MN Cajimat","year":"2012","unstructured":"Cajimat MN, Milazzo ML, Bradley RD, Fulhorst CF (2012) Ocozocoautla de espinosa virus and hemorrhagic fever, Mexico. Emerg Infect Dis 18:401\u2013405","journal-title":"Emerg Infect Dis"},{"key":"17_CR27","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1097\/00006454-199906000-00013","volume":"18","author":"LL Barton","year":"1999","unstructured":"Barton LL, Mets MB (1999) Lymphocytic choriomeningitis virus: pediatric pathogen and fetal teratogen. Pediatr Infect Dis J 18:540\u2013541","journal-title":"Pediatr Infect Dis J"},{"key":"17_CR28","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1086\/321897","volume":"33","author":"LL Barton","year":"2001","unstructured":"Barton LL, Mets MB (2001) Congenital lymphocytic choriomeningitis virus infection: decade of rediscovery. Clin Infect Dis 33:370\u2013374","journal-title":"Clin Infect Dis"},{"key":"17_CR29","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1067\/mob.2002.126297","volume":"187","author":"LL Barton","year":"2002","unstructured":"Barton LL, Mets MB, Beauchamp CL (2002) Lymphocytic choriomeningitis virus: emerging fetal teratogen. Am J Obstet Gynecol 187:1715\u20131716","journal-title":"Am J Obstet Gynecol"},{"key":"17_CR30","first-page":"486","volume":"116","author":"PB Jahrling","year":"1992","unstructured":"Jahrling PB, Peters CJ (1992) Lymphocytic choriomeningitis virus. A neglected pathogen of man. Arch Pathol Lab Med 116:486\u2013488","journal-title":"Arch Pathol Lab Med"},{"key":"17_CR31","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S0002-9394(00)00570-5","volume":"130","author":"MB Mets","year":"2000","unstructured":"Mets MB, Barton LL, Khan AS, Ksiazek TG (2000) Lymphocytic choriomeningitis virus: an underdiagnosed cause of congenital chorioretinitis. Am J Ophthalmol 130:209\u2013215","journal-title":"Am J Ophthalmol"},{"key":"17_CR32","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1056\/NEJMoa053240","volume":"354","author":"SA Fischer","year":"2006","unstructured":"Fischer SA, Graham MB, Kuehnert MJ, Kotton CN, Srinivasan A et al (2006) Transmission of lymphocytic choriomeningitis virus by organ transplantation. N Engl J Med 354:2235\u20132249","journal-title":"N Engl J Med"},{"key":"17_CR33","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1056\/NEJMoa073785","volume":"358","author":"G Palacios","year":"2008","unstructured":"Palacios G, Druce J, Du L, Tran T, Birch C et al (2008) A new arenavirus in a cluster of fatal transplant-associated diseases. N Engl J Med 358:991\u2013998","journal-title":"N Engl J Med"},{"key":"17_CR34","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1056\/NEJMp068021","volume":"354","author":"CJ Peters","year":"2006","unstructured":"Peters CJ (2006) Lymphocytic choriomeningitis virus-an old enemy up to new tricks. N Engl J Med 354:2208\u20132211","journal-title":"N Engl J Med"},{"key":"17_CR35","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1001\/jama.287.18.2391","volume":"287","author":"L Borio","year":"2002","unstructured":"Borio L, Inglesby T, Peters CJ, Schmaljohn AL, Hughes JM et al (2002) Hemorrhagic fever viruses as biological weapons: medical and public health management. JAMA 287:2391\u20132405","journal-title":"JAMA"},{"key":"17_CR36","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0065-3527(02)58004-0","volume":"58","author":"EB Damonte","year":"2002","unstructured":"Damonte EB, Coto CE (2002) Treatment of arenavirus infections: from basic studies to the challenge of antiviral therapy. Adv Virus Res 58:125\u2013155","journal-title":"Adv Virus Res"},{"key":"17_CR37","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1097\/00042560-199608150-00003","volume":"12","author":"P Harvie","year":"1996","unstructured":"Harvie P, Omar RF, Dusserre N, Desormeaux A, Gourde P et al (1996) Antiviral efficacy and toxicity of ribavirin in murine acquired immunodeficiency syndrome model. J Acquir Immune Defic Syndr Hum Retrovirol 12:451\u2013461","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"17_CR38","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1006\/taap.1996.8080","volume":"143","author":"RF Omar","year":"1997","unstructured":"Omar RF, Harvie P, Gourde P, Desormeaux A, Tremblay M et al (1997) Antiviral efficacy and toxicity of ribavirin and foscarnet each given alone or in combination in the murine AIDS model. Toxicol Appl Pharmacol 143:140\u2013151","journal-title":"Toxicol Appl Pharmacol"},{"key":"17_CR39","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1517\/14656566.2.8.1317","volume":"2","author":"NJ Snell","year":"2001","unstructured":"Snell NJ (2001) Ribavirin\u2014current status of a broad spectrum antiviral agent. Expert Opin Pharmacother 2:1317\u20131324","journal-title":"Expert Opin Pharmacother"},{"key":"17_CR40","first-page":"239","volume":"263","author":"DA Enria","year":"2002","unstructured":"Enria DA, Barrera Oro JG (2002) Junin virus vaccines. Curr Top Microbiol Immunol 263:239\u2013261","journal-title":"Curr Top Microbiol Immunol"},{"key":"17_CR41","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1086\/514211","volume":"177","author":"JI Maiztegui","year":"1998","unstructured":"Maiztegui JI, McKee KT Jr, Barrera Oro JG, Harrison LH, Gibbs PH et al (1998) Protective efficacy of a live attenuated vaccine against Argentine hemorrhagic fever. AHF Study Group. J Infect Dis 177:277\u2013283","journal-title":"J Infect Dis"},{"key":"17_CR42","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.coviro.2013.04.007","volume":"3","author":"D Falzarano","year":"2013","unstructured":"Falzarano D, Feldmann H (2013) Vaccines for viral hemorrhagic fevers\u2014progress and shortcomings. Curr Opin Virol 3:343\u2013351","journal-title":"Curr Opin Virol"},{"key":"17_CR43","doi-asserted-by":"publisher","first-page":"5606","DOI":"10.1128\/JVI.00276-09","volume":"83","author":"CG Albarino","year":"2009","unstructured":"Albarino CG, Bergeron E, Erickson BR, Khristova ML, Rollin PE et al (2009) Efficient reverse genetics generation of infectious Junin viruses differing in glycoprotein processing. J Virol 83:5606\u20135614","journal-title":"J Virol"},{"key":"17_CR44","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1128\/JVI.02102-10","volume":"85","author":"SF Emonet","year":"2011","unstructured":"Emonet SF, Seregin AV, Yun NE, Poussard AL, Walker AG et al (2011) Rescue from cloned cDNAs and in vivo characterization of recombinant pathogenic Romero and live-attenuated Candid #1 strains of Junin virus, the causative agent of Argentine hemorrhagic fever disease. J Virol 85:1473\u20131483","journal-title":"J Virol"},{"key":"17_CR45","doi-asserted-by":"publisher","first-page":"13793","DOI":"10.1128\/JVI.78.24.13793-13803.2004","volume":"78","author":"M Hass","year":"2004","unstructured":"Hass M, Golnitz U, Muller S, Becker-Ziaja B, Gunther S (2004) Replicon system for Lassa virus. J Virol 78:13793\u201313803","journal-title":"J Virol"},{"key":"17_CR46","doi-asserted-by":"publisher","first-page":"4020","DOI":"10.1128\/JVI.02556-10","volume":"85","author":"CG Albarino","year":"2011","unstructured":"Albarino CG, Bird BH, Chakrabarti AK, Dodd KA, Erickson BR et al (2011) Efficient rescue of recombinant Lassa virus reveals the influence of S segment noncoding regions on virus replication and virulence. J Virol 85:4020\u20134024","journal-title":"J Virol"},{"key":"17_CR47","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1056\/NEJM198601023140104","volume":"314","author":"JB McCormick","year":"1986","unstructured":"McCormick JB, King IJ, Webb PA, Scribner CL, Craven RB et al (1986) Lassa fever. Effective therapy with ribavirin. N Engl J Med 314:20\u201326","journal-title":"N Engl J Med"},{"key":"17_CR48","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1093\/clind\/24.4.718","volume":"24","author":"PE Kilgore","year":"1997","unstructured":"Kilgore PE, Ksiazek TG, Rollin PE, Mills JN, Villagra MR et al (1997) Treatment of Bolivian hemorrhagic fever with intravenous ribavirin. Clin Infect Dis 24:718\u2013722","journal-title":"Clin Infect Dis"},{"key":"17_CR49","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1128\/AAC.32.9.1304","volume":"32","author":"KT McKee Jr","year":"1988","unstructured":"McKee KT Jr, Huggins JW, Trahan CJ, Mahlandt BG (1988) Ribavirin prophylaxis and therapy for experimental argentine hemorrhagic fever. Antimicrob Agents Chemother 32:1304\u20131309","journal-title":"Antimicrob Agents Chemother"},{"key":"17_CR50","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.antiviral.2008.01.004","volume":"78","author":"P Leyssen","year":"2008","unstructured":"Leyssen P, De Clercq E, Neyts J (2008) Molecular strategies to inhibit the replication of RNA viruses. Antiviral Res 78:9\u201325","journal-title":"Antiviral Res"},{"key":"17_CR51","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.virusres.2004.11.006","volume":"107","author":"WB Parker","year":"2005","unstructured":"Parker WB (2005) Metabolism and antiviral activity of ribavirin. Virus Res 107:165\u2013171","journal-title":"Virus Res"},{"key":"17_CR52","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1097\/00001432-200112000-00015","volume":"14","author":"CE Cameron","year":"2001","unstructured":"Cameron CE, Castro C (2001) The mechanism of action of ribavirin: lethal mutagenesis of RNA virus genomes mediated by the viral RNA-dependent RNA polymerase. Curr Opin Infect Dis 14:757\u2013764","journal-title":"Curr Opin Infect Dis"},{"key":"17_CR53","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1038\/82191","volume":"6","author":"S Crotty","year":"2000","unstructured":"Crotty S, Maag D, Arnold JJ, Zhong W, Lau JYN et al (2000) The broad-spectrum antiviral ribonucleotide, ribavirin, is an RNA virus mutagen. Nat Med 6:1375\u20131379","journal-title":"Nat Med"},{"key":"17_CR54","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0042-6822(02)00046-6","volume":"308","author":"CM Ruiz-Jarabo","year":"2003","unstructured":"Ruiz-Jarabo CM, Ly C, Domingo E, de la Torre JC (2003) Lethal mutagenesis of the prototypic arenavirus lymphocytic choriomeningitis virus (LCMV). Virology 308:37\u201347","journal-title":"Virology"},{"key":"17_CR55","doi-asserted-by":"publisher","first-page":"5777","DOI":"10.1073\/pnas.1101143108","volume":"108","author":"HH Hoffmann","year":"2011","unstructured":"Hoffmann HH, Kunz A, Simon VA, Palese P, Shaw ML (2011) Broad-spectrum antiviral that interferes with de novo pyrimidine biosynthesis. Proc Natl Acad Sci U S A 108:5777\u20135782","journal-title":"Proc Natl Acad Sci U S A"},{"key":"17_CR56","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1128\/JVI.02275-13","volume":"88","author":"E Ortiz-Riano","year":"2014","unstructured":"Ortiz-Riano E, Ngo N, Devito S, Eggink D, Munger J et al (2014) Inhibition of arenavirus by A3, a pyrimidine biosynthesis inhibitor. J Virol 88:878\u2013889","journal-title":"J Virol"},{"key":"17_CR57","doi-asserted-by":"publisher","first-page":"e2614","DOI":"10.1371\/journal.pntd.0002614","volume":"7","author":"BB Gowen","year":"2013","unstructured":"Gowen BB, Juelich TL, Sefing EJ, Brasel T, Smith JK et al (2013) Favipiravir (T-705) inhibits Junin virus infection and reduces mortality in a guinea pig model of Argentine hemorrhagic fever. PLoS Negl Trop Dis 7:e2614","journal-title":"PLoS Negl Trop Dis"},{"key":"17_CR58","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1128\/AAC.01219-10","volume":"55","author":"M Mendenhall","year":"2011","unstructured":"Mendenhall M, Russell A, Juelich T, Messina EL, Smee DF et al (2011) T-705 (favipiravir) inhibition of arenavirus replication in cell culture. Antimicrob Agents Chemother 55:782\u2013787","journal-title":"Antimicrob Agents Chemother"},{"key":"17_CR59","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.antiviral.2005.10.008","volume":"69","author":"TC Bolken","year":"2005","unstructured":"Bolken TC, Laquerre S, Zhang Y, Bailey TR, Pevear DC et al (2005) Identification and characterization of potent small molecule inhibitor of hemorrhagic fever New World arenaviruses. Antiviral Res 69:86\u201397","journal-title":"Antiviral Res"},{"key":"17_CR60","doi-asserted-by":"publisher","first-page":"18734","DOI":"10.1074\/jbc.M802089200","volume":"283","author":"AM Lee","year":"2008","unstructured":"Lee AM, Rojek JM, Spiropoulou CF, Gundersen AT, Jin W et al (2008) Unique small molecule entry inhibitors of hemorrhagic fever arena viruses. J Biol Chem 283:18734\u201318742","journal-title":"J Biol Chem"},{"key":"17_CR61","doi-asserted-by":"publisher","first-page":"3470","DOI":"10.1128\/JVI.74.8.3470-3477.2000","volume":"74","author":"KJ Lee","year":"2000","unstructured":"Lee KJ, Novella IS, Teng MN, Oldstone MB, de La Torre JC (2000) NP and L proteins of lymphocytic choriomeningitis virus (LCMV) are sufficient for efficient transcription and replication of LCMV genomic RNA analogs. J Virol 74:3470\u20133477","journal-title":"J Virol"},{"key":"17_CR62","doi-asserted-by":"publisher","first-page":"10700","DOI":"10.1128\/JVI.77.19.10700-10705.2003","volume":"77","author":"T Strecker","year":"2003","unstructured":"Strecker T, Eichler R, Meulen J, Weissenhorn W, Dieter Klenk H et al (2003) Lassa virus Z protein is a matrix protein and sufficient for the release of virus-like particles [corrected]. J Virol 77:10700\u201310705","journal-title":"J Virol"},{"key":"17_CR63","doi-asserted-by":"publisher","first-page":"12978","DOI":"10.1073\/pnas.2133782100","volume":"100","author":"M Perez","year":"2003","unstructured":"Perez M, Craven RC, de la Torre JC (2003) The small RING finger protein Z drives arenavirus budding: implications for antiviral strategies. Proc Natl Acad Sci U S A 100:12978\u201312983","journal-title":"Proc Natl Acad Sci U S A"},{"key":"17_CR64","doi-asserted-by":"publisher","first-page":"4191","DOI":"10.1128\/JVI.80.8.4191-4195.2006","volume":"80","author":"S Urata","year":"2006","unstructured":"Urata S, Noda T, Kawaoka Y, Yokosawa H, Yasuda J (2006) Cellular factors required for Lassa virus budding. J Virol 80:4191\u20134195","journal-title":"J Virol"},{"key":"17_CR65","doi-asserted-by":"publisher","first-page":"7895","DOI":"10.1073\/pnas.1332709100","volume":"100","author":"DD Pinschewer","year":"2003","unstructured":"Pinschewer DD, Perez M, Sanchez AB, de la Torre JC (2003) Recombinant lymphocytic choriomeningitis virus expressing vesicular stomatitis virus glycoprotein. Proc Natl Acad Sci U S A 100:7895\u20137900","journal-title":"Proc Natl Acad Sci U S A"},{"key":"17_CR66","doi-asserted-by":"publisher","first-page":"2866","DOI":"10.1128\/JVI.77.5.2866-2872.2003","volume":"77","author":"WR Beyer","year":"2003","unstructured":"Beyer WR, Popplau D, Garten W, von Laer D, Lenz O (2003) Endoproteolytic processing of the lymphocytic choriomeningitis virus glycoprotein by the subtilase SKI-1\/S1P. J Virol 77:2866\u20132872","journal-title":"J Virol"},{"key":"17_CR67","doi-asserted-by":"publisher","first-page":"7677","DOI":"10.1128\/JVI.00560-08","volume":"82","author":"JM Rojek","year":"2008","unstructured":"Rojek JM, Sanchez AB, Nguyen NT, de la Torre JC, Kunz S (2008) Different mechanisms of cell entry by human-pathogenic Old World and New World arenaviruses. J Virol 82:7677\u20137687","journal-title":"J Virol"},{"key":"17_CR68","doi-asserted-by":"publisher","first-page":"6393","DOI":"10.1128\/JVI.76.12.6393-6397.2002","volume":"76","author":"KJ Lee","year":"2002","unstructured":"Lee KJ, Perez M, Pinschewer DD, de la Torre JC (2002) Identification of the lymphocytic choriomeningitis virus (LCMV) proteins required to rescue LCMV RNA analogs into LCMV-like particles. J Virol 76:6393\u20136397","journal-title":"J Virol"},{"key":"17_CR69","doi-asserted-by":"publisher","first-page":"3307","DOI":"10.1128\/JVI.05503-11","volume":"86","author":"E Ortiz-Riano","year":"2012","unstructured":"Ortiz-Riano E, Cheng BY, de la Torre JC, Martinez-Sobrido L (2012) Self-association of lymphocytic choriomeningitis virus nucleoprotein is mediated by its N-terminal region and is not required for its anti-interferon function. J Virol 86:3307\u20133317","journal-title":"J Virol"},{"key":"17_CR70","doi-asserted-by":"publisher","first-page":"13038","DOI":"10.1128\/JVI.05834-11","volume":"85","author":"E Ortiz-Riano","year":"2011","unstructured":"Ortiz-Riano E, Cheng BY, de la Torre JC, Martinez-Sobrido L (2011) The C-terminal region of lymphocytic choriomeningitis virus nucleoprotein contains distinct and segregable functional domains involved in NP-Z interaction and counteraction of the type I interferon response. J Virol 85:13038\u201313048","journal-title":"J Virol"},{"key":"17_CR71","doi-asserted-by":"publisher","first-page":"7728","DOI":"10.1128\/JVI.00187-12","volume":"86","author":"C Pythoud","year":"2012","unstructured":"Pythoud C, Rodrigo WW, Pasqual G, Rothenberger S, Martinez-Sobrido L et al (2012) Arenavirus nucleoprotein targets interferon regulatory factor-activating kinase IKKepsilon. J Virol 86:7728\u20137738","journal-title":"J Virol"},{"key":"17_CR72","doi-asserted-by":"publisher","first-page":"11330","DOI":"10.1128\/JVI.00763-09","volume":"83","author":"L Martinez-Sobrido","year":"2009","unstructured":"Martinez-Sobrido L, Emonet S, Giannakas P, Cubitt B, Garcia-Sastre A et al (2009) Identification of amino acid residues critical for the anti-interferon activity of the nucleoprotein of the prototypic arenavirus lymphocytic choriomeningitis virus. J Virol 83:11330\u201311340","journal-title":"J Virol"},{"key":"17_CR73","doi-asserted-by":"publisher","first-page":"12696","DOI":"10.1128\/JVI.00882-07","volume":"81","author":"L Martinez-Sobrido","year":"2007","unstructured":"Martinez-Sobrido L, Giannakas P, Cubitt B, Garcia-Sastre A, de la Torre JC (2007) Differential inhibition of type I interferon induction by arenavirus nucleoproteins. J Virol 81:12696\u201312703","journal-title":"J Virol"},{"key":"17_CR74","doi-asserted-by":"publisher","first-page":"9192","DOI":"10.1128\/JVI.00555-06","volume":"80","author":"L Martinez-Sobrido","year":"2006","unstructured":"Martinez-Sobrido L, Zuniga EI, Rosario D, Garcia-Sastre A, de la Torre JC (2006) Inhibition of the type I interferon response by the nucleoprotein of the prototypic arenavirus lymphocytic choriomeningitis virus. J Virol 80:9192\u20139199","journal-title":"J Virol"},{"key":"17_CR75","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.3390\/v2112443","volume":"2","author":"P Borrow","year":"2010","unstructured":"Borrow P, Martinez-Sobrido L, de la Torre JC (2010) Inhibition of the type I interferon antiviral response during arenavirus infection. Viruses 2:2443\u20132480","journal-title":"Viruses"},{"key":"17_CR76","doi-asserted-by":"publisher","first-page":"6240","DOI":"10.1128\/JVI.00610-15","volume":"89","author":"C Pythoud","year":"2015","unstructured":"Pythoud C, Rothenberger S, Martinez-Sobrido L, de la Torre JC, Kunz S (2015) Lymphocytic choriomeningitis virus differentially affects the virus-induced type I interferon response and mitochondrial apoptosis mediated by RIG-I\/MAVS. J Virol 89:6240\u20136250","journal-title":"J Virol"},{"key":"17_CR77","doi-asserted-by":"publisher","first-page":"8185","DOI":"10.1128\/JVI.07240-11","volume":"86","author":"WW Rodrigo","year":"2012","unstructured":"Rodrigo WW, Ortiz-Riano E, Pythoud C, Kunz S, de la Torre JC et al (2012) Arenavirus nucleoproteins prevent activation of nuclear factor kappa B. J Virol 86:8185\u20138197","journal-title":"J Virol"},{"key":"17_CR78","doi-asserted-by":"publisher","first-page":"19967","DOI":"10.1073\/pnas.1108910108","volume":"108","author":"S Igonet","year":"2011","unstructured":"Igonet S, Vaney MC, Vonrhein C, Bricogne G, Stura EA et al (2011) X-ray structure of the arenavirus glycoprotein GP2 in its postfusion hairpin conformation. Proc Natl Acad Sci U S A 108:19967\u201319972","journal-title":"Proc Natl Acad Sci U S A"},{"key":"17_CR79","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.3390\/v4102162","volume":"4","author":"DJ Burri","year":"2012","unstructured":"Burri DJ, da Palma JR, Kunz S, Pasquato A (2012) Envelope glycoprotein of arenaviruses. Viruses 4:2162\u20132181","journal-title":"Viruses"},{"key":"17_CR80","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1126\/science.282.5396.2079","volume":"282","author":"W Cao","year":"1998","unstructured":"Cao W, Henry MD, Borrow P, Yamada H, Elder JH et al (1998) Identification of alpha-dystroglycan as a receptor for lymphocytic choriomeningitis virus and Lassa fever virus. Science 282:2079\u20132081","journal-title":"Science"},{"key":"17_CR81","first-page":"111","volume":"262","author":"S Kunz","year":"2002","unstructured":"Kunz S, Borrow P, Oldstone MB (2002) Receptor structure, binding, and cell entry of arenaviruses. Curr Top Microbiol Immunol 262:111\u2013137","journal-title":"Curr Top Microbiol Immunol"},{"key":"17_CR82","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1083\/jcb.200104103","volume":"155","author":"S Kunz","year":"2001","unstructured":"Kunz S, Sevilla N, McGavern DB, Campbell KP, Oldstone MB (2001) Molecular analysis of the interaction of LCMV with its cellular receptor [alpha]-dystroglycan. J Cell Biol 155:301\u2013310","journal-title":"J Cell Biol"},{"key":"17_CR83","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/nature05539","volume":"446","author":"SR Radoshitzky","year":"2007","unstructured":"Radoshitzky SR, Abraham J, Spiropoulou CF, Kuhn JH, Nguyen D et al (2007) Transferrin receptor 1 is a cellular receptor for New World haemorrhagic fever arenaviruses. Nature 446:92\u201396","journal-title":"Nature"},{"key":"17_CR84","doi-asserted-by":"publisher","first-page":"e1002232","DOI":"10.1371\/journal.ppat.1002232","volume":"7","author":"G Pasqual","year":"2011","unstructured":"Pasqual G, Rojek JM, Masin M, Chatton JY, Kunz S (2011) Old world arenaviruses enter the host cell via the multivesicular body and depend on the endosomal sorting complex required for transport. PLoS Pathog 7:e1002232","journal-title":"PLoS Pathog"},{"key":"17_CR85","doi-asserted-by":"publisher","first-page":"9451","DOI":"10.1128\/JVI.00499-07","volume":"81","author":"AA Capul","year":"2007","unstructured":"Capul AA, Perez M, Burke E, Kunz S, Buchmeier MJ et al (2007) Arenavirus Z-glycoprotein association requires Z myristoylation but not functional RING or late domains. J Virol 81:9451\u20139460","journal-title":"J Virol"},{"key":"17_CR86","doi-asserted-by":"publisher","first-page":"11443","DOI":"10.1128\/JVI.78.20.11443-11448.2004","volume":"78","author":"M Perez","year":"2004","unstructured":"Perez M, Greenwald DL, de la Torre JC (2004) Myristoylation of the RING finger Z protein is essential for arenavirus budding. J Virol 78:11443\u201311448","journal-title":"J Virol"},{"key":"17_CR87","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/1743-422X-3-93","volume":"3","author":"T Strecker","year":"2006","unstructured":"Strecker T, Maisa A, Daffis S, Eichler R, Lenz O et al (2006) The role of myristoylation in the membrane association of the Lassa virus matrix protein Z. Virol J 3:93","journal-title":"Virol J"},{"key":"17_CR88","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.3390\/v4091651","volume":"4","author":"ME Loureiro","year":"2012","unstructured":"Loureiro ME, D\u2019Antuono A, Levingston Macleod JM, Lopez N (2012) Uncovering viral protein-protein interactions and their role in arenavirus life cycle. Viruses 4:1651\u20131667","journal-title":"Viruses"},{"key":"17_CR89","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.antiviral.2008.08.002","volume":"80","author":"JC Torre de la","year":"2008","unstructured":"de la Torre JC (2008) Reverse genetics approaches to combat pathogenic arenaviruses. Antiviral Res 80:239\u2013250","journal-title":"Antiviral Res"},{"key":"17_CR90","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.virol.2011.01.013","volume":"411","author":"SE Emonet","year":"2011","unstructured":"Emonet SE, Urata S, de la Torre JC (2011) Arenavirus reverse genetics: new approaches for the investigation of arenavirus biology and development of antiviral strategies. Virology 411:416\u2013425","journal-title":"Virology"},{"key":"17_CR91","doi-asserted-by":"crossref","unstructured":"Cheng, B. Y., Ortiz-Riano, E., de la Torre, J. C. & Martinez-Sobrido, L. Arenavirus Genome Rearrangement for the Development of Live Attenuated Vaccines. Journal of virology 89, 7373\u20137384, doi:10.1128\/JVI.00307-15 (2015).","DOI":"10.1128\/JVI.00307-15"},{"key":"17_CR92","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.3390\/v4102137","volume":"4","author":"E Ortiz-Riano","year":"2012","unstructured":"Ortiz-Riano E, Cheng BY, de la Torre JC, Martinez-Sobrido L (2012) D471G mutation in LCMV-NP affects its ability to self-associate and results in a dominant negative effect in viral RNA synthesis. Viruses 4:2137\u20132161","journal-title":"Viruses"},{"key":"17_CR93","doi-asserted-by":"publisher","first-page":"13811","DOI":"10.1128\/JVI.01908-14","volume":"88","author":"M Russier","year":"2014","unstructured":"Russier M, Reynard S, Carnec X, Baize S (2014) The exonuclease domain of Lassa virus nucleoprotein is involved in antigen-presenting-cell-mediated NK cell responses. J Virol 88:13811\u201313820","journal-title":"J Virol"},{"key":"17_CR94","doi-asserted-by":"publisher","first-page":"13923","DOI":"10.1128\/JVI.01923-14","volume":"88","author":"S Reynard","year":"2014","unstructured":"Reynard S, Russier M, Fizet A, Carnec X, Baize S (2014) Exonuclease domain of the Lassa virus nucleoprotein is critical to avoid RIG-I signaling and to inhibit the innate immune response. J Virol 88:13923\u201313927","journal-title":"J Virol"},{"key":"17_CR95","doi-asserted-by":"publisher","first-page":"5949","DOI":"10.1128\/JVI.00104-15","volume":"89","author":"AV Seregin","year":"2015","unstructured":"Seregin AV, Yun NE, Miller M, Aronson J, Smith JK et al (2015) The glycoprotein precursor gene of Junin virus determines the virulence of Romero strain and attenuation of Candid #1 strain in a representative animal model of Argentine Hemorrhagic Fever. J Virol 89:5949\u20135956","journal-title":"J Virol"},{"key":"17_CR96","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1099\/vir.0.051102-0","volume":"94","author":"E Ortiz-Riano","year":"2013","unstructured":"Ortiz-Riano E, Cheng BY, Carlos de la Torre J, Martinez-Sobrido L (2013) Arenavirus reverse genetics for vaccine development. J Gen Virol 94:1175\u20131188","journal-title":"J Gen Virol"},{"key":"17_CR97","first-page":"e50662","volume":"78","author":"BY Cheng","year":"2013","unstructured":"Cheng BY, Ortiz-Riano E, de la Torre JC, Martinez-Sobrido L (2013) Generation of recombinant arenavirus for vaccine development in FDA-approved Vero cells. J Vis Exp 78:e50662","journal-title":"J Vis Exp"},{"key":"17_CR98","doi-asserted-by":"crossref","unstructured":"Cheng, B. Y., Ortiz-Riano, E., Nogales, A., de la Torre, J. C. & Martinez-Sobrido, L. Development of liveattenuated arenavirus vaccines based on codon deoptimization. Journal of virology, doi:10.1128\/JVI.03401-14 (2015).","DOI":"10.1128\/JVI.03401-14"},{"key":"17_CR99","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1128\/JVI.02229-10","volume":"85","author":"WW Rodrigo","year":"2011","unstructured":"Rodrigo WW, de la Torre JC, Martinez-Sobrido L (2011) Use of single-cycle infectious lymphocytic choriomeningitis virus to study hemorrhagic fever arenaviruses. J Virol 85:1684\u20131695","journal-title":"J Virol"},{"key":"17_CR100","doi-asserted-by":"publisher","first-page":"3473","DOI":"10.1073\/pnas.0900088106","volume":"106","author":"SF Emonet","year":"2009","unstructured":"Emonet SF, Garidou L, McGavern DB, de la Torre JC (2009) Generation of recombinant lymphocytic choriomeningitis viruses with trisegmented genomes stably expressing two additional genes of interest. Proc Natl Acad Sci U S A 106:3473\u20133478","journal-title":"Proc Natl Acad Sci U S A"},{"key":"17_CR101","doi-asserted-by":"publisher","first-page":"7928","DOI":"10.1128\/JVI.00486-11","volume":"85","author":"DL Popkin","year":"2011","unstructured":"Popkin DL, Teijaro JR, Lee AM, Lewicki H, Emonet S et al (2011) Expanded potential for recombinant trisegmented lymphocytic choriomeningitis viruses: protein production, antibody production, and in vivo assessment of biological function of genes of interest. J Virol 85:7928\u20137932","journal-title":"J Virol"},{"key":"17_CR102","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/nm.2104","volume":"16","author":"L Flatz","year":"2010","unstructured":"Flatz L, Hegazy AN, Bergthaler A, Verschoor A, Claus C et al (2010) Development of replication-defective lymphocytic choriomeningitis virus vectors for the induction of potent CD8+ T cell immunity. Nat Med 16:339\u2013345","journal-title":"Nat Med"},{"key":"17_CR103","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1128\/JVI.65.4.1863-1869.1991","volume":"65","author":"M Salvato","year":"1991","unstructured":"Salvato M, Borrow P, Shimomaye E, Oldstone MB (1991) Molecular basis of viral persistence: a single amino acid change in the glycoprotein of lymphocytic choriomeningitis virus is associated with suppression of the antiviral cytotoxic T-lymphocyte response and establishment of persistence. J Virol 65:1863\u20131869","journal-title":"J Virol"},{"key":"17_CR104","doi-asserted-by":"publisher","first-page":"e1003105","DOI":"10.1371\/journal.ppat.1003105","volume":"9","author":"C Nisii","year":"2013","unstructured":"Nisii C, Castilletti C, Raoul H, Hewson R, Brown D et al (2013) Biosafety Level-4 laboratories in Europe: opportunities for public health, diagnostics, and research. PLoS Pathog 9:e1003105","journal-title":"PLoS Pathog"},{"key":"17_CR105","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/0378-1119(91)90434-D","volume":"108","author":"H Niwa","year":"1991","unstructured":"Niwa H, Yamamura K, Miyazaki J (1991) Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108:193\u2013199","journal-title":"Gene"},{"key":"17_CR106","doi-asserted-by":"publisher","first-page":"4663","DOI":"10.1073\/pnas.0600652103","volume":"103","author":"L Flatz","year":"2006","unstructured":"Flatz L, Bergthaler A, de la Torre JC, Pinschewer DD (2006) Recovery of an arenavirus entirely from RNA polymerase I\/II-driven cDNA. Proc Natl Acad Sci U S A 103:4663\u20134668","journal-title":"Proc Natl Acad Sci U S A"},{"key":"17_CR107","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/0959-437X(95)80035-2","volume":"5","author":"J Heix","year":"1995","unstructured":"Heix J, Grummt I (1995) Species specificity of transcription by RNA polymerase I. Curr Opin Genet Dev 5:652\u2013656","journal-title":"Curr Opin Genet Dev"},{"key":"17_CR108","doi-asserted-by":"publisher","first-page":"2715","DOI":"10.1016\/j.vaccine.2012.02.015","volume":"30","author":"RD Hess","year":"2012","unstructured":"Hess RD, Weber F, Watson K, Schmitt S (2012) Regulatory, biosafety and safety challenges for novel cells as substrates for human vaccines. Vaccine 30:2715\u20132727","journal-title":"Vaccine"},{"key":"17_CR109","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1128\/JVI.01433-09","volume":"84","author":"L Martinez-Sobrido","year":"2010","unstructured":"Martinez-Sobrido L, Cadagan R, Steel J, Basler CF, Palese P et al (2010) Hemagglutinin-pseudotyped green fluorescent protein-expressing influenza viruses for the detection of influenza virus neutralizing antibodies. J Virol 84:2157\u20132163","journal-title":"J Virol"},{"key":"17_CR110","doi-asserted-by":"publisher","first-page":"8591","DOI":"10.1128\/JVI.01081-13","volume":"87","author":"SF Baker","year":"2013","unstructured":"Baker SF, Guo H, Albrecht RA, Garcia-Sastre A, Topham DJ et al (2013) Protection against lethal influenza with a viral mimic. J Virol 87:8591\u20138605","journal-title":"J Virol"},{"key":"17_CR111","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1128\/JVI.77.2.1184-1194.2003","volume":"77","author":"M Perez","year":"2003","unstructured":"Perez M, de la Torre JC (2003) Characterization of the genomic promoter of the prototypic arenavirus lymphocytic choriomeningitis virus. J Virol 77:1184\u20131194","journal-title":"J Virol"},{"key":"17_CR112","doi-asserted-by":"publisher","first-page":"4519","DOI":"10.1128\/JVI.79.7.4519-4526.2005","volume":"79","author":"DD Pinschewer","year":"2005","unstructured":"Pinschewer DD, Perez M, de la Torre JC (2005) Dual role of the lymphocytic choriomeningitis virus intergenic region in transcription termination and virus propagation. J Virol 79:4519\u20134526","journal-title":"J Virol"},{"key":"17_CR113","doi-asserted-by":"publisher","first-page":"19743","DOI":"10.1073\/pnas.1112742108","volume":"108","author":"PJ Kranzusch","year":"2011","unstructured":"Kranzusch PJ, Whelan SP (2011) Arenavirus Z protein controls viral RNA synthesis by locking a polymerase-promoter complex. Proc Natl Acad Sci U S A 108:19743\u201319748","journal-title":"Proc Natl Acad Sci U S A"},{"key":"17_CR114","doi-asserted-by":"publisher","first-page":"11071","DOI":"10.1128\/JVI.79.17.11071-11081.2005","volume":"79","author":"AB Sanchez","year":"2005","unstructured":"Sanchez AB, Perez M, Cornu T, de la Torre JC (2005) RNA interference-mediated virus clearance from cells both acutely and chronically infected with the prototypic arenavirus lymphocytic choriomeningitis virus. J Virol 79:11071\u201311081","journal-title":"J Virol"},{"key":"17_CR115","doi-asserted-by":"publisher","first-page":"10759","DOI":"10.1128\/JVI.01144-12","volume":"86","author":"E Bergeron","year":"2012","unstructured":"Bergeron E, Chakrabarti AK, Bird BH, Dodd KA, McMullan LK et al (2012) Reverse genetics recovery of Lujo virus and role of virus RNA secondary structures in efficient virus growth. J Virol 86:10759\u201310765","journal-title":"J Virol"},{"key":"17_CR116","doi-asserted-by":"publisher","first-page":"12241","DOI":"10.1128\/JVI.75.24.12241-12251.2001","volume":"75","author":"N Lopez","year":"2001","unstructured":"Lopez N, Jacamo R, Franze-Fernandez MT (2001) Transcription and RNA replication of tacaribe virus genome and antigenome analogs require N and L proteins: Z protein is an inhibitor of these processes. J Virol 75:12241\u201312251","journal-title":"J Virol"},{"key":"17_CR117","doi-asserted-by":"publisher","first-page":"6357","DOI":"10.1128\/JVI.00019-09","volume":"83","author":"S Lan","year":"2009","unstructured":"Lan S, McLay Schelde L, Wang J, Kumar N, Ly H et al (2009) Development of infectious clones for virulent and avirulent pichinde viruses: a model virus to study arenavirus-induced hemorrhagic fevers. J Virol 83:6357\u20136362","journal-title":"J Virol"},{"key":"17_CR118","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1128\/JVI.02925-13","volume":"88","author":"M Patterson","year":"2014","unstructured":"Patterson M, Seregin A, Huang C, Kolokoltsova O, Smith J et al (2014) Rescue of a recombinant Machupo virus from cloned cDNAs and in vivo characterization in interferon (alphabeta\/gamma) receptor double knockout mice. J Virol 88:1914\u20131923","journal-title":"J Virol"},{"key":"17_CR119","doi-asserted-by":"publisher","first-page":"9345","DOI":"10.1073\/pnas.96.16.9345","volume":"96","author":"G Neumann","year":"1999","unstructured":"Neumann G, Watanabe T, Ito H, Watanabe S, Goto H et al (1999) Generation of influenza A viruses entirely from cloned cDNAs. Proc Natl Acad Sci U S A 96:9345\u20139350","journal-title":"Proc Natl Acad Sci U S A"},{"key":"17_CR120","doi-asserted-by":"crossref","first-page":"9679","DOI":"10.1128\/JVI.73.11.9679-9682.1999","volume":"73","author":"E Fodor","year":"1999","unstructured":"Fodor E, Devenish L, Engelhardt OG, Palese P, Brownlee GG et al (1999) Rescue of influenza A virus from recombinant DNA. J Virol 73:9679\u20139682","journal-title":"J Virol"},{"key":"17_CR121","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.antiviral.2012.12.003","volume":"97","author":"L McLay","year":"2013","unstructured":"McLay L, Ansari A, Liang Y, Ly H (2013) Targeting virulence mechanisms for the prevention and therapy of arenaviral hemorrhagic fever. Antiviral Res 97:81\u201392","journal-title":"Antiviral Res"},{"key":"17_CR122","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.virol.2006.01.012","volume":"350","author":"AB Sanchez","year":"2006","unstructured":"Sanchez AB, de la Torre JC (2006) Rescue of the prototypic Arenavirus LCMV entirely from plasmid. Virology 350:370\u2013380","journal-title":"Virology"},{"key":"17_CR123","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.virol.2014.12.006","volume":"476","author":"A Nogales","year":"2015","unstructured":"Nogales A, Baker SF, Martinez-Sobrido L (2015) Replication-competent influenza A viruses expressing a red fluorescent protein. Virology 476:206\u2013216","journal-title":"Virology"},{"key":"17_CR124","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1006\/viro.1999.9895","volume":"262","author":"R Flick","year":"1999","unstructured":"Flick R, Hobom G (1999) Transient bicistronic vRNA segments for indirect selection of recombinant influenza viruses. Virology 262:93\u2013103","journal-title":"Virology"},{"key":"17_CR125","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.virol.2005.09.050","volume":"345","author":"A Vieira Machado","year":"2006","unstructured":"Vieira Machado A, Naffakh N, Gerbaud S, van der Werf S, Escriou N (2006) Recombinant influenza A viruses harboring optimized dicistronic NA segment with an extended native 5\u2032 terminal sequence: induction of heterospecific B and T cell responses in mice. Virology 345:73\u201387","journal-title":"Virology"},{"key":"17_CR126","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1128\/JVI.02055-08","volume":"83","author":"A Marschalek","year":"2009","unstructured":"Marschalek A, Finke S, Schwemmle M, Mayer D, Heimrich B et al (2009) Attenuation of rabies virus replication and virulence by picornavirus internal ribosome entry site elements. J Virol 83:1911\u20131919","journal-title":"J Virol"},{"key":"17_CR127","doi-asserted-by":"crossref","first-page":"6254","DOI":"10.1128\/JVI.68.10.6254-6261.1994","volume":"68","author":"A Garcia-Sastre","year":"1994","unstructured":"Garcia-Sastre A, Muster T, Barclay WS, Percy N, Palese P (1994) Use of a mammalian internal ribosomal entry site element for expression of a foreign protein by a transfectant influenza virus. J Virol 68:6254\u20136261","journal-title":"J Virol"},{"key":"17_CR128","doi-asserted-by":"publisher","first-page":"11316","DOI":"10.1128\/JVI.01301-13","volume":"87","author":"H Goto","year":"2013","unstructured":"Goto H, Muramoto Y, Noda T, Kawaoka Y (2013) The genome-packaging signal of the influenza A virus genome comprises a genome incorporation signal and a genome-bundling signal. J Virol 87:11316\u201311322","journal-title":"J Virol"},{"key":"17_CR129","doi-asserted-by":"publisher","first-page":"10348","DOI":"10.1128\/JVI.79.16.10348-10355.2005","volume":"79","author":"Y Liang","year":"2005","unstructured":"Liang Y, Hong Y, Parslow TG (2005) cis-Acting packaging signals in the influenza virus PB1, PB2, and PA genomic RNA segments. J Virol 79:10348\u201310355","journal-title":"J Virol"},{"key":"17_CR130","first-page":"139","volume":"262","author":"BJ Meyer","year":"2002","unstructured":"Meyer BJ, de la Torre JC, Southern PJ (2002) Arenaviruses: genomic RNAs, transcription, and replication. Curr Top Microbiol Immunol 262:139\u2013157","journal-title":"Curr Top Microbiol Immunol"},{"key":"17_CR131","first-page":"159","volume":"262","author":"MJ Buchmeier","year":"2002","unstructured":"Buchmeier MJ (2002) Arenaviruses: protein structure and function. Curr Top Microbiol Immunol 262:159\u2013173","journal-title":"Curr Top Microbiol Immunol"},{"issue":"Pt 4","key":"17_CR132","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1099\/0022-1317-64-4-833","volume":"64","author":"PR Young","year":"1983","unstructured":"Young PR, Howard CR (1983) Fine structure analysis of Pichinde virus nucleocapsids. J Gen Virol 64(Pt 4):833\u2013842","journal-title":"J Gen Virol"},{"key":"17_CR133","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1128\/JVI.02267-07","volume":"82","author":"GA Marsh","year":"2008","unstructured":"Marsh GA, Rabadan R, Levine AJ, Palese P (2008) Highly conserved regions of influenza a virus polymerase gene segments are critical for efficient viral RNA packaging. J Virol 82:2295\u20132304","journal-title":"J Virol"},{"key":"17_CR134","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1099\/vir.0.81227-0","volume":"87","author":"A Kohl","year":"2006","unstructured":"Kohl A, Lowen AC, Leonard VH, Elliott RM (2006) Genetic elements regulating packaging of the Bunyamwera orthobunyavirus genome. J Gen Virol 87:177\u2013187","journal-title":"J Gen Virol"},{"key":"17_CR135","doi-asserted-by":"publisher","first-page":"204ra131","DOI":"10.1126\/scitranslmed.3006827","volume":"5","author":"M Lavanya","year":"2013","unstructured":"Lavanya M, Cuevas CD, Thomas M, Cherry S, Ross SR (2013) siRNA screen for genes that affect Junin virus entry uncovers voltage-gated calcium channels as a therapeutic target. Sci Transl Med 5:204ra131","journal-title":"Sci Transl Med"},{"key":"17_CR136","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1128\/JVI.76.3.1488-1495.2002","volume":"76","author":"WR Beyer","year":"2002","unstructured":"Beyer WR, Westphal M, Ostertag W, von Laer D (2002) Oncoretrovirus and lentivirus vectors pseudotyped with lymphocytic choriomeningitis virus glycoprotein: generation, concentration, and broad host range. J Virol 76:1488\u20131495","journal-title":"J Virol"},{"key":"17_CR137","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1089\/hum.2004.15.1091","volume":"15","author":"H Miletic","year":"2004","unstructured":"Miletic H, Fischer YH, Neumann H, Hans V, Stenzel W et al (2004) Selective transduction of malignant glioma by lentiviral vectors pseudotyped with lymphocytic choriomeningitis virus glycoproteins. Hum Gene Ther 15:1091\u20131100","journal-title":"Hum Gene Ther"},{"key":"17_CR138","doi-asserted-by":"publisher","first-page":"2820","DOI":"10.1128\/JVI.01870-09","volume":"84","author":"EA Gomme","year":"2010","unstructured":"Gomme EA, Faul EJ, Flomenberg P, McGettigan JP, Schnell MJ (2010) Characterization of a single-cycle rabies virus-based vaccine vector. J Virol 84:2820\u20132831","journal-title":"J Virol"},{"key":"17_CR139","doi-asserted-by":"publisher","first-page":"7148","DOI":"10.1016\/j.vaccine.2006.06.061","volume":"24","author":"A Bozac","year":"2006","unstructured":"Bozac A, Berto E, Vasquez F, Grandi P, Caputo A et al (2006) Expression of human immunodeficiency virus type 1 tat from a replication-deficient herpes simplex type 1 vector induces antigen-specific T cell responses. Vaccine 24:7148\u20137158","journal-title":"Vaccine"},{"key":"17_CR140","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.virol.2007.09.023","volume":"372","author":"Y Tang","year":"2008","unstructured":"Tang Y, Swanstrom R (2008) Development and characterization of a new single cycle vaccine vector in the simian immunodeficiency virus model system. Virology 372:72\u201384","journal-title":"Virology"},{"key":"17_CR141","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.virol.2006.04.003","volume":"351","author":"PW Mason","year":"2006","unstructured":"Mason PW, Shustov AV, Frolov I (2006) Production and characterization of vaccines based on flaviviruses defective in replication. Virology 351:432\u2013443","journal-title":"Virology"},{"key":"17_CR142","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/nbt1400","volume":"26","author":"DC Chang","year":"2008","unstructured":"Chang DC, Liu WJ, Anraku I, Clark DC, Pollitt CC et al (2008) Single-round infectious particles enhance immunogenicity of a DNA vaccine against West Nile virus. Nat Biotechnol 26:571\u2013577","journal-title":"Nat Biotechnol"},{"key":"17_CR143","doi-asserted-by":"publisher","first-page":"3810","DOI":"10.1128\/JVI.00074-09","volume":"83","author":"P Halfmann","year":"2009","unstructured":"Halfmann P, Ebihara H, Marzi A, Hatta Y, Watanabe S et al (2009) Replication-deficient ebolavirus as a vaccine candidate. J Virol 83:3810\u20133815","journal-title":"J Virol"},{"key":"17_CR144","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1128\/JVI.1.5.1091-1092.1967","volume":"1","author":"S Wainwright","year":"1967","unstructured":"Wainwright S, Mims CA (1967) Plaque assay for lymphocytic choriomeningitis virus based on hemadsorption interference. J Virol 1:1091\u20131092","journal-title":"J Virol"},{"key":"17_CR145","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1271\/bbb.68.565","volume":"68","author":"Y Nakajima","year":"2004","unstructured":"Nakajima Y, Kobayashi K, Yamagishi K, Enomoto T, Ohmiya Y (2004) cDNA cloning and characterization of a secreted luciferase from the luminous Japanese ostracod, Cypridina noctiluca. Biosci Biotechnol Biochem 68:565\u2013570","journal-title":"Biosci Biotechnol Biochem"}],"container-title":["Methods in Molecular Biology","Vaccine Design"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-3387-7_17","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T17:24:45Z","timestamp":1600449885000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4939-3387-7_17"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"ISBN":["9781493933853","9781493933877"],"references-count":145,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-3387-7_17","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}